Infliximab Biosimilar - Anti-TNF alpha Antibody - Low endotoxin, Azide free (A323510)

Infliximab Biosimilar - Anti-TNF alpha Antibody - Low endotoxin, Azide free

Recombinant chimeric monoclonal antibody to TNF alpha.

ELISA, FACS, Functional Assay, In Vivo

Human, Cynomolgus Macaque

Mouse / Human

Monoclonal

IgG1

kappa

Unconjugated

Protein A affinity chromatography.

This antibody has a predicted MW of 145.98 kDa.

> 95% (by SDS-PAGE and SEC-HPLC).

Lyophilized

Reconstitute with 100µl of sterile double-distilled water to bring antibody to 1mg/ml concentration. Gently shake to solubilize completely. Do not vortex!

Lyophilized from 25mM Histadine, pH 6.2, with 8% Sucrose and 0.01% Tween80.

Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.

APC1, APC1 protein, Cachectin, DIF, Differentiation inducing factor, Macrophage cytotoxic factor, soluble form, Tnf, TNF a, TNF macrophage derived, TNF monocyte derived, TNF superfamily member 2 , TNF superfamily, member 2, TNF, macrophage derived, TNF, monocyte derived, TNF-a, TNF-alpha, TNFA, TNFA_HUMAN, TNFSF2, Tumor necrosis factor, Tumor necrosis factor (TNF superfamily member 2) , Tumor necrosis factor alpha, Tumor necrosis factor ligand superfamily member 2, Tumor Necrosis Factor, Membrane Form, Tumor necrosis factor, soluble form

This product is for research use only. It is not intended for diagnostic or therapeutic use.